Focal segmental glomerulosclerosis historical perspective: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
It is believed that Theodor Fahr, a German pathologist, first was first to describe "progressive lipoid nephrosis" in 1925 and to draw an illustration of focal segmental glomerulosclerosis (FSGS).<ref>{{cite book | last = Fahr |first = T | authorlink = |coauthors = | title = Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane.| publisher = Springer |date = 1925 | location = Vienna| pages = 156-472 | url = | doi = | id = | isbn = }}</ref> At the time, he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. FSGS was then described in 1957 by Dr. Arnold Rich, a pathologist at Johns Hopkins University.<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> His original article "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis" was originally published in "Bulletin of the Johns Hopkins Hospital".<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> In his original description, he noted the presence of segmental sclerosis in juxtamedullary glomeruli of autopsies of uremic children with nephrosis.<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> | It is believed that Theodor Fahr, a German pathologist, first was first to describe "progressive lipoid nephrosis" in 1925 and to draw an illustration of focal segmental glomerulosclerosis (FSGS).<ref>{{cite book | last = Fahr |first = T | authorlink = |coauthors = | title = Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane.| publisher = Springer |date = 1925 | location = Vienna| pages = 156-472 | url = | doi = | id = | isbn = }}</ref> At the time, he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. FSGS was then described in 1957 by Dr. Arnold Rich, a pathologist at Johns Hopkins University.<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> His original article "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis" was originally published in "Bulletin of the Johns Hopkins Hospital".<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> In his original description, he noted the presence of segmental sclerosis in juxtamedullary glomeruli of autopsies of uremic children with nephrosis.<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> In 1970, Jacob Churg and colleagues finally classified FSGS as a unique renal glomerulopathy in the " Pathology of the Nephrotic Syndrome in Children: Report for the International International Study of Kidney Disease in Children" in view of its clinical and pathological features, and its steroid-resistance in comparison to minimal change disease.<ref name="pmid4193942">{{cite journal| author=Churg J, Habib R, White RH| title=Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. | journal=Lancet | year= 1970 | volume= 760 | issue= 1 | pages= 1299-302 | pmid=4193942 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4193942 }} </ref> | ||
==References== | ==References== | ||
Revision as of 17:46, 3 December 2013
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis historical perspective |
|
FDA on Focal segmental glomerulosclerosis historical perspective |
|
CDC on Focal segmental glomerulosclerosis historical perspective |
|
Focal segmental glomerulosclerosis historical perspective in the news |
|
Blogs on Focal segmental glomerulosclerosis historical perspective |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis historical perspective |
It is believed that Theodor Fahr, a German pathologist, first was first to describe "progressive lipoid nephrosis" in 1925 and to draw an illustration of focal segmental glomerulosclerosis (FSGS).[1] At the time, he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. FSGS was then described in 1957 by Dr. Arnold Rich, a pathologist at Johns Hopkins University.[2] His original article "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis" was originally published in "Bulletin of the Johns Hopkins Hospital".[2] In his original description, he noted the presence of segmental sclerosis in juxtamedullary glomeruli of autopsies of uremic children with nephrosis.[2] In 1970, Jacob Churg and colleagues finally classified FSGS as a unique renal glomerulopathy in the " Pathology of the Nephrotic Syndrome in Children: Report for the International International Study of Kidney Disease in Children" in view of its clinical and pathological features, and its steroid-resistance in comparison to minimal change disease.[3]
References
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ 2.0 2.1 2.2 RICH AR (1957). "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis". Bull Johns Hopkins Hosp. 100 (4): 173–86. PMID 13426687.
- ↑ Churg J, Habib R, White RH (1970). "Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children". Lancet. 760 (1): 1299–302. PMID 4193942.